Elise Lavoie-Lebel MD, MSc , Madeleine Ennis PhD , Regina Renner MD, MPH , Sarah Munro PhD , Robin Leung RN , Jennifer Chisholm PhD , Brigid Dineley MD, MHSc , Liv Knutzen MD , Julie Robertson MD , Jessica Liauw MD, MHSc
{"title":"Clinical Care Pathways for Second and Third Trimester Termination of Pregnancy for Medical Reasons in Canada","authors":"Elise Lavoie-Lebel MD, MSc , Madeleine Ennis PhD , Regina Renner MD, MPH , Sarah Munro PhD , Robin Leung RN , Jennifer Chisholm PhD , Brigid Dineley MD, MHSc , Liv Knutzen MD , Julie Robertson MD , Jessica Liauw MD, MHSc","doi":"10.1016/j.jogc.2025.102770","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Termination of pregnancy in the second/third trimester for fetal or maternal complications (i.e., for medical reasons) is an essential health service. We aimed to describe the systems-level pathways for this care in Canada.</div></div><div><h3>Methods</h3><div>We conducted one-on-one semi-structured interviews with maternal–fetal medicine (MFM), medical genetics, and nursing/social work clinicians at the 10 academic MFM sites in Canada. We conducted qualitative content analysis to identify categories describing the clinical care pathway. We triangulated data from participants within sites and then compared data across sites to describe similarities and differences in care. We used NVivo14 software for coding.</div></div><div><h3>Results</h3><div>We recruited 28 participants representing all sites: 10 MFM specialists, 9 medical geneticists/genetic counsellors, and 9 nurses/social workers. We identified 4 main categories describing the clinical care pathway: (1) initial visit and clinic structure, (2) offering termination, (3) provision of procedural and medication termination, and (4) post-termination care. Across sites, although clinic structure and post-termination care were similar, there were differences in offering the option of termination (e.g., variable indications qualifying for approval) and variations in details regarding the provision of procedural and medical termination (e.g., upper gestational age limits for procedural vs. medical approaches).</div></div><div><h3>Conclusions</h3><div>Clinical care pathways for second/third trimester termination for medical reasons are variable across Canadian academic MFM centres, especially regarding circumstances under which termination is offered and details regarding the provision of procedural and medical termination. These differences provide opportunities to inform efforts to optimize equitable and comprehensive services in Canada.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 3","pages":"Article 102770"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of obstetrics and gynaecology Canada","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1701216325000106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Termination of pregnancy in the second/third trimester for fetal or maternal complications (i.e., for medical reasons) is an essential health service. We aimed to describe the systems-level pathways for this care in Canada.
Methods
We conducted one-on-one semi-structured interviews with maternal–fetal medicine (MFM), medical genetics, and nursing/social work clinicians at the 10 academic MFM sites in Canada. We conducted qualitative content analysis to identify categories describing the clinical care pathway. We triangulated data from participants within sites and then compared data across sites to describe similarities and differences in care. We used NVivo14 software for coding.
Results
We recruited 28 participants representing all sites: 10 MFM specialists, 9 medical geneticists/genetic counsellors, and 9 nurses/social workers. We identified 4 main categories describing the clinical care pathway: (1) initial visit and clinic structure, (2) offering termination, (3) provision of procedural and medication termination, and (4) post-termination care. Across sites, although clinic structure and post-termination care were similar, there were differences in offering the option of termination (e.g., variable indications qualifying for approval) and variations in details regarding the provision of procedural and medical termination (e.g., upper gestational age limits for procedural vs. medical approaches).
Conclusions
Clinical care pathways for second/third trimester termination for medical reasons are variable across Canadian academic MFM centres, especially regarding circumstances under which termination is offered and details regarding the provision of procedural and medical termination. These differences provide opportunities to inform efforts to optimize equitable and comprehensive services in Canada.
期刊介绍:
Journal of Obstetrics and Gynaecology Canada (JOGC) is Canada"s peer-reviewed journal of obstetrics, gynaecology, and women"s health. Each monthly issue contains original research articles, reviews, case reports, commentaries, and editorials on all aspects of reproductive health. JOGC is the original publication source of evidence-based clinical guidelines, committee opinions, and policy statements that derive from standing or ad hoc committees of the Society of Obstetricians and Gynaecologists of Canada. JOGC is included in the National Library of Medicine"s MEDLINE database, and abstracts from JOGC are accessible on PubMed.